Suplatast tosilate is an an immunoregulatory compound. It is formulated as hard gelatin capsules and dry syrup for oral route of administration. It is under development for idiopathic pulmonary ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase I for Overactive Bladder.

However, since no comparison was made between different treatments, we think it could not have biased the results. Responders reached clinical remission in 6.6 days in average; most of them within ...